Suppr超能文献

[早期干预在轻度高血压中的效用:来自大规模临床试验的证据]

[Usefulness of early-stage intervention in mild hypertension: evidence from large-scale clinical trials].

作者信息

Hashimoto Takanao, Ohkubo Takayoshi, Imai Yutaka

机构信息

Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences.

出版信息

Nihon Rinsho. 2008 Aug;66(8):1464-70.

Abstract

Mild hypertension(stage 1 hypertension at ESC-ESH guideline 2007) defined as systolic blood pressure 140-159 mmHg and/or diastolic blood pressure 90-99 mmHg has been described as an established risk factor for cardiovascular events in guidelines on hypertension. Many trials have established the usefulness of treatment to moderate and severe hypertension with blood pressure levels of 160/100 or more. Some recent trials including patients with mild hypertension have also shown that antihypertensive treatment significantly reduced the risk of cardiovascular events, especially in patients with history of cardiovascular disease or diabetes. However, more studies are required to clarify the most appropriate antihypertensive drugs for the treatment of mild hypertension.

摘要

轻度高血压(按照2007年欧洲心脏病学会-欧洲高血压学会指南属于1级高血压)定义为收缩压140 - 159 mmHg和/或舒张压90 - 99 mmHg,在高血压指南中已被描述为心血管事件的既定危险因素。许多试验已证实治疗血压水平为160/100及以上的中度和重度高血压是有效的。一些近期纳入轻度高血压患者的试验也表明,降压治疗显著降低了心血管事件风险,尤其是有心血管疾病或糖尿病史的患者。然而,需要更多研究来明确治疗轻度高血压最合适的降压药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验